Repare Therapeutics Inc.
RPTX
$1.36
$0.118.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.29% | -82.24% | -191.09% | 137.67% | 11.46% |
| Total Depreciation and Amortization | -10.28% | -4.02% | -3.56% | 13.61% | 11.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.51% | -10.46% | 14.93% | 19.48% | -54.63% |
| Change in Net Operating Assets | 36.12% | 94.17% | 94.04% | -254.54% | 41.27% |
| Cash from Operations | 2.95% | 7.09% | 11.16% | 137.54% | 5.00% |
| Capital Expenditure | -- | -- | -- | -- | -123.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.14% | 26.87% | -75.80% | -227.10% | -0.19% |
| Cash from Investing | -0.92% | 26.87% | -74.89% | -203.86% | -6.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.05% | -41.55% | -100.00% | -9.20% | -36.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.05% | -41.55% | -100.00% | -9.20% | -36.36% |
| Foreign Exchange rate Adjustments | -222.54% | 116.09% | -102.56% | -4,100.00% | 127.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.10% | 108.82% | -295.42% | 78.85% | -9.95% |